These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 19318976)
1. Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes. Sardella G; Colantonio R; De Luca L; Conti G; Di Roma A; Mancone M; Canali E; Benedetti G; Fedele F J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):469-73. PubMed ID: 19318976 [TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter). Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609 [TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. Latib A; Mussardo M; Ielasi A; Tarsia G; Godino C; Al-Lamee R; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A JACC Cardiovasc Interv; 2011 Feb; 4(2):155-64. PubMed ID: 21349453 [TBL] [Abstract][Full Text] [Related]
4. Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice. Appleby CE; Khattar RS; Morgan K; Clarke B; Curzen N; Neyses L; Fath-Ordoubadi F EuroIntervention; 2011 Jan; 6(6):748-53. PubMed ID: 21205600 [TBL] [Abstract][Full Text] [Related]
5. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis. Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152 [TBL] [Abstract][Full Text] [Related]
7. Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials. Lee JM; Park J; Kang J; Jeon KH; Jung JH; Lee SE; Han JK; Kim HL; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS JACC Cardiovasc Interv; 2015 Mar; 8(3):382-394. PubMed ID: 25703886 [TBL] [Abstract][Full Text] [Related]
8. Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis. Nojima Y; Yasuoka Y; Kume K; Adachi H; Hattori S; Matsutera R; Kohama Y; Sasaki T Coron Artery Dis; 2014 Dec; 25(8):638-44. PubMed ID: 25076360 [TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty. Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915 [TBL] [Abstract][Full Text] [Related]
10. Selective drug-eluting stent implantation for high-risk patients with acute ST-elevation myocardial infarction: rationale and safety. Prasad SB; David T; Malaiapan Y; Cameron JD; Meredith IT Catheter Cardiovasc Interv; 2011 Feb; 77(2):193-200. PubMed ID: 20549694 [TBL] [Abstract][Full Text] [Related]
11. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675 [TBL] [Abstract][Full Text] [Related]
12. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study. Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry. Manari A; Ortolani P; Guastaroba P; Marzaroli P; Menozzi M; Magnavacchi P; Varani E; Vignali L; Campo G; Marzocchi A J Cardiovasc Med (Hagerstown); 2011 Feb; 12(2):102-9. PubMed ID: 20814313 [TBL] [Abstract][Full Text] [Related]
14. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis. Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705 [TBL] [Abstract][Full Text] [Related]
15. Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry. Tamburino C; Di Salvo ME; Capodanno D; Capranzano P; Parisi R; Mirabella F; Scardaci F; Ussia G; Galassi AR; Fiscella D; Mehran R; Dangas G Catheter Cardiovasc Interv; 2009 Feb; 73(2):243-8. PubMed ID: 19156896 [TBL] [Abstract][Full Text] [Related]
16. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry. Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis. Almalla M; Schröder J; Pross V; Marx N; Hoffmann R Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557 [TBL] [Abstract][Full Text] [Related]
18. Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. Hehrlein C; Dietz U; Kubica J; Jørgensen E; Hoffmann E; Naber C; Lesiak M; Schneider H; Wiemer M; Tölg R; Richardt G Cardiovasc Revasc Med; 2012; 13(5):260-4. PubMed ID: 22867706 [TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry. Costa JR; Sousa A; Moreira AC; Costa RA; Cano M; Maldonado G; Campos C; Carballo M; Pavanello R; Sousa JE JACC Cardiovasc Interv; 2010 Jan; 3(1):12-8. PubMed ID: 20129562 [TBL] [Abstract][Full Text] [Related]
20. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry. Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]